Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIGS: Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
NCT04192435Phase 4Completed
- Start
- May 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in surgical site infection (SSI) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Incidence of Surgical Site Infection at 30 days. Started May 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04192435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04192435.